Level of Survivin in Breast Cancer Patients Serum

Authors

  • - Irmayanti Medical Faculty of Universitas Muslim Indonesia, Makassar, Indonesia
  • Bahrun U Faculty of Medicine, Hasanuddin University, Indonesia
  • Kartika I D Ibnu Sina Hospital, YW-UMI, Makassar, Indonesia
  • Irsandy F Ibnu Sina Hospital, YW-UMI, Makassar, Indonesia
  • Sanna A T Ibnu Sina Hospital, YW-UMI, Makassar, Indonesia

DOI:

https://doi.org/10.31344/ijhhs.v8i20.703

Keywords:

breast cancer, survivin, serum

Abstract

Objectives: The progressivity of breast cancer is controlled by a balance between cell proliferation and apoptosis. Dysregulation of apoptotic pathways leading to disorders such as cancer, autoimmune, and immunodeficiency diseases, as well as neurodegenerative disorders. Cancer cells be resistant to apoptosis by expressing an anti-apoptotic protein i.e. Apoptosis Protein Inhibitor (IAP). Survivin is an apoptotic inhibitor protein (IAP) that selectively plays a role in cancer cells, inhibits apoptosis, promotes cell division and improves angiogenesis. Detection of survivin in the blood can serve as an ideal marker for cancer diagnosis and detection. This study aims to determine the levels of survivin in breast cancer and its role as a marker of breast cancer. Methods: A cross-sectional method was conducted in Dr. Wahidin Sudirohusodo Hospital Makassar and Hasanuddin University Academic Hospital during the period from July to August 2017. There were 72 subjects (20 control, 26 non-metastatic breast cancer and 26 metastatic breast cancer), with age range of 30-61 years. The survivin test using human survivin kit with enzyme linked immunosorbent assay method (ELISA). Results: The results showed that serum surviving level in breast cancer group was significantly higher than control group (p=0,000), also higher in the metastasis group than in non-metastatic, but statistically not significant (p=0,147). Conclusion: Survivin level serum in breast cancer patients was increase.

International Journal of Human and Health Sciences Supplementary Issue 01: 2024 Page: S57

Downloads

Published

2024-05-19

How to Cite

Irmayanti, .-., U, B., I D, K., F, I., & A T, S. (2024). Level of Survivin in Breast Cancer Patients Serum. International Journal of Human and Health Sciences (IJHHS), 8(20), S57. https://doi.org/10.31344/ijhhs.v8i20.703

Issue

Supplementary Issue-1: 2024

Section

E-Poster Presentation

License

Copyright (c) 2024 - Irmayanti, Bahrun U, Kartika I D, Irsandy F, Sanna A T

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:

  1. Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

  2. Creative Commons Licence
    Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.